Steven DE VLEESCHOUWER,Matthias VAN WOENSEL,Karim AMIGHI,Nathalie WAUTHOZ,Rémi ROSIERE
申请号：
US15778359
公开号：
US20180344658A1
申请日:
2016.11.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention generally relates to a new formulation containing nanoparticles encapsulating siRNA for the use of RNAi technology for gene silencing of galectin-1 involved in tumour progression. More in particular the present invention relates to the use of RNAi molecules for treating central nervous cancer, more in particular for treating glioblastoma multiforme (GBM).
